Penn Medicine Provider
Dermatology
Brian C. Capell, MD, PhD
4.9
(145)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location

About me

  • Assistant Professor of Dermatology
  • Assistant Professor of Dermatology in Genetics

Education and training

  • Medical School: New York University School of Medicine
  • Residency: Pennsylvania Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

145 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
great doctor
April 2025
5.0
5.0
he's extremely knowledgeable, professional and thorough.
April 2025
5.0
5.0
the best in dermatology
April 2025
5.0
5.0
feel like he is a good listener and attentive to my clinical needs

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Capell is a Penn Medicine physician.

Qualifications and experience

My research

Egolf S, Zou J, Anderson A, Simpson CL, Aubert Y, Prouty S, Ge K, Seykora JT, Capell BC MLL4 mediates differentiation and tumor suppression through ferroptosis , Sci Adv, 7(50): 2021,eabj9141


Huang S, Kuri P, Aubert Y, Brewster M, Li N, Farrelly O, Rice G, Bae H, Prouty S, Dentchev T, Luo W, Capell BC, Rompolas P. Lgr6 marks epidermal stem cells with a nerve-dependent role in wound re-epithelialization , Cell Stem Cell, ell Stem Cell: 2021,1582-1596


Pacella G, Capell BC. Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma , Exp Dermatol, 30(8): 2021,1115-1125


Ko EK, Capell BC. Methyltransferases in the Pathogenesis of Keratinocyte Cancers , Cancers (Basel), 13: 2021,3402


Maldonado López A, Capell BC. The METTL3-m(6)A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer , Genes (Basel), 12: 2021,1019


Zheng Q, Capell BC, Parekh V, O'Day C, Atillasoy C, Bashir HM, Yeh C, Shim EH, Prouty SM, Dentchev T, Lee V, Wushanley L, Kweon Y, Suzuki-Horiuchi Y, Pear W, Grice EA, Seykora JT. Whole-Exome and Transcriptome Analysis of UV-Exposed Epidermis and Carcinoma In Situ Reveals Early Drivers of Carcinogenesis , J Invest Dermatol, 141: 2021,295-307


Egolf S, Capell BC LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma? , Expert opin ther targets, 24(7): 2020,671-678


Aubert Yann, Egolf Shaun, Capell Brian C The Unexpected Noncatalytic Roles of Histone Modifiers in Development and Disease. , Trends in genetics : TIG, 35(9): 2019,645-657


Egolf Shaun, Aubert Yann, Doepner Miriam, Anderson Amy, Maldonado-Lopez Alexandra, Pacella Gina, Lee Jessica, Ko Eun Kyung, Zou Jonathan, Lan Yemin, Simpson Cory L, Ridky Todd, Capell Brian C LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors. , Cell reports, 28(8): 2019,1981-1992.e7


Lin-Shiao Enrique, Lan Yemin, Coradin Mariel, Anderson Amy, Donahue Greg, Simpson Cory L, Sen Payel, Saffie Rizwan, Busino Luca, Garcia Benjamin A, Berger Shelley L, Capell Brian C KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. , Genes & development, 32(2): 2018,181-193